Embecta Corp EMBC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $6.25
- Day Range
- $6.02–6.26
- 52-Week Range
- $2.77–14.81
- Bid/Ask
- $6.13 / $6.65
- Shares Outstanding
- 56.66M
- Market Cap
- $348.46M
- Volume/Avg
- 933,858 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 4.49
- Price/Sales
- 0.36
- Dividend Yield (Trailing)
- 5.22%
- Dividend Yield (Forward)
- 0.65%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 5.22%
Company Profile
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,850
- Website
- https://www.embecta.com
Valuation
Metric | EMBC |
|---|---|
Price/Earnings (Normalized) | 4.49 |
Price/Book Value | — |
Price/Sales | 0.36 |
Price/Cash Flow | 1.97 |
Price/Earnings
EMBC
Financial Strength
Metric | EMBC |
|---|---|
Quick Ratio | 0.95 |
Current Ratio | 1.68 |
Interest Coverage | 2.29 |
Quick Ratio
EMBC
Profitability
Metric | EMBC |
|---|---|
Return on Assets (Normalized) | 10.74% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 23.53% |
Return on Assets
EMBC
Medical Instruments & Supplies Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|&lkw&<Kj | LOCK|^?? | $149B | |||
| Becton Dickinson & Co BDX | LOCK|!^T | LOCK|mCjB | $59B | |||
| Alcon Inc ALC | LOCK|mK&z%p | LOCK|^BzT^ | $35B | |||
| ResMed Inc RMD | LOCK|#FnShvB | LOCK|$KCkw | $33B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|r@rx^& | LOCK|?WQ%F | $33B | |||
| West Pharmaceutical Services Inc WST | LOCK|SSFJ#LW | LOCK|>>H | $29B | |||
| Solventum Corp SOLV | LOCK|cxQ^jj? | LOCK|fw | $15B | |||
| Baxter International Inc BAX | LOCK|c#P | LOCK|bT%G | $13B | |||
| The Cooper Companies Inc COO | LOCK|HY>z<x | LOCK|&@LN> | $12B | |||
| Align Technology Inc ALGN | LOCK|L#X%lwz | LOCK|!&&^ | $12B |